Skip to main content

For informational and research purposes only.

Medical DisclaimerTerms of Use

Fatty Acid

Algal Oil: The Complete Supplement Guide

By Doserly Editorial Team
On this page

Quick Reference Card

Attribute

Common Name

Detail
Algal Oil

Attribute

Other Names / Aliases

Detail
Algae Oil, Microalgal Oil, Vegan Omega-3, Plant-Based DHA/EPA

Attribute

Category

Detail
Fatty Acid (Omega-3 PUFA)

Attribute

Primary Forms & Variants

Detail
Schizochytrium sp. oil (DHA-dominant, most common); Nannochloropsis sp. oil (provides both EPA and DHA); Ulkenia sp. oil (DHA-rich); Life's DHA / life'sOMEGA formulations

Attribute

Typical Dose Range

Detail
250-500 mg combined EPA+DHA per day (general health); up to 1-2 g per day (therapeutic)

Attribute

RDA / AI / UL

Detail
No RDA or UL established for DHA or EPA specifically. AI for total omega-3 (as ALA): 1.1 g/day (women), 1.6 g/day (men). EFSA recommends 250 mg combined EPA+DHA daily for cardiovascular health.

Attribute

Common Delivery Forms

Detail
Softgel capsules, liquid oil, gummies

Attribute

Best Taken With / Without Food

Detail
With food containing some dietary fat to enhance absorption

Attribute

Key Cofactors

Detail
Vitamin E (antioxidant protection of PUFAs), Vitamin D3 (synergistic cardiovascular and immune support), Astaxanthin (oxidative stability), Phospholipids (enhanced absorption)

Attribute

Storage Notes

Detail
Refrigerate after opening to slow oxidation. Store away from heat, light, and moisture. Tightly seal container. Discard if a strong rancid or excessively fishy odor develops.

Overview

The Basics

Algal oil is a plant-based source of omega-3 fatty acids, specifically DHA (docosahexaenoic acid) and, in some formulations, EPA (eicosapentaenoic acid). If you have ever wondered where fish get their omega-3s in the first place, the answer is algae. Fish accumulate DHA and EPA by eating microalgae or smaller organisms that have already eaten algae. Algal oil cuts out the middleman and delivers these fatty acids directly from the original source.

DHA is one of the most important structural fats in your body. It makes up roughly 40% of the polyunsaturated fatty acids in your brain and is a major component of the retina in your eyes [1]. Your body can technically produce small amounts of DHA from alpha-linolenic acid (ALA), a plant-based omega-3 found in foods like flaxseed and walnuts. However, this conversion is notoriously inefficient, typically less than 5-10% for EPA and even lower for DHA [2]. This means that for many people, especially those who do not eat fish, getting preformed DHA from a supplement may be the most reliable way to maintain adequate levels.

Algal oil has gained significant popularity among vegans, vegetarians, and anyone looking for an omega-3 source without the environmental concerns, contaminant risks, or fishy aftertaste associated with fish oil. Research has shown that the DHA from algal oil is bioequivalent to that from cooked salmon, meaning your body absorbs and uses it just as effectively [3].

The Science

Algal oil is derived from marine microalgae, predominantly species within the genus Schizochytrium, which are heterotrophic protists cultivated in controlled fermentation environments. These organisms naturally produce triacylglycerols rich in DHA (C22:6n-3), the longest and most highly unsaturated of the common omega-3 PUFAs [1]. Some newer algal oil formulations utilize Nannochloropsis sp. or engineered strains that also produce significant quantities of EPA (C20:5n-3) [4].

The rationale for algal oil supplementation rests on the limited endogenous conversion of ALA to long-chain omega-3s. In vivo studies consistently demonstrate that hepatic desaturation and elongation of ALA to EPA proceeds at rates below 15%, with further conversion to DHA estimated at less than 5% [2]. This conversion is further impaired by high dietary omega-6 intake, as linoleic acid competes for the same delta-6 desaturase enzyme [5]. Population data from the National Health and Nutrition Examination Survey (NHANES) indicate that average dietary EPA+DHA intake among U.S. adults not taking supplements is approximately 90 mg/day, well below the 250-500 mg/day recommended by multiple international bodies [6].

A crossover bioavailability study (n=32) published in the Journal of the American Dietetic Association demonstrated that DHA from algal oil capsules (600 mg DHA/day for two weeks) produced equivalent increases in plasma and erythrocyte phospholipid DHA compared to an equivalent dose from cooked salmon [3]. This bioequivalence finding has been cited across major health organizations as evidence that algal oil is a viable alternative to fish-derived omega-3 sources.

Chemical & Nutritional Identity

Property

Primary Active Compound

Value
DHA (Docosahexaenoic acid, C22:6n-3)

Property

Secondary Active Compound

Value
EPA (Eicosapentaenoic acid, C20:5n-3) — present in some formulations

Property

Chemical Class

Value
Long-chain polyunsaturated fatty acid (LC-PUFA), Omega-3

Property

DHA Molecular Formula

Value
C22H32O2

Property

DHA Molecular Weight

Value
328.49 g/mol

Property

DHA CAS Number

Value
6217-54-5

Property

DHA PubChem CID

Value
445580

Property

EPA Molecular Formula

Value
C20H30O2

Property

EPA Molecular Weight

Value
302.45 g/mol

Property

EPA CAS Number

Value
10417-94-4

Property

Category

Value
Omega-3 Fatty Acid Supplement

Property

RDA / AI / UL

Value
No RDA or UL for EPA/DHA. AI for ALA: 1.1 g (women), 1.6 g (men). EFSA: 250 mg combined EPA+DHA daily for heart health.

Algal oil supplements typically contain DHA and EPA in the natural triglyceride form, which is the same chemical structure found in fish tissue. This is in contrast to some pharmaceutical fish oil preparations that use ethyl ester forms. The triglyceride form has been shown to have somewhat higher bioavailability than ethyl esters in pharmacokinetic studies [7].

The DHA/EPA ratio in algal oil depends on the microalgae species used. Schizochytrium sp. produces primarily DHA with minimal EPA, while Nannochloropsis sp. produces both EPA and DHA. Most consumer algal oil products contain 200-500 mg DHA and 0-500 mg EPA per serving, with considerable variation between brands and formulations.

Mechanism of Action

The Basics

Omega-3 fatty acids from algal oil work in your body through two main pathways. First, DHA and EPA become part of your cell membranes, particularly in the brain, retina, and heart. Think of your cell membranes as flexible walls that control what goes in and out of each cell. DHA makes these walls more fluid and responsive, which is especially important in tissues that rely on rapid signaling, like your brain and eyes [1].

Second, EPA and DHA serve as building blocks for specialized anti-inflammatory molecules. Your body converts them into compounds called resolvins, protectins, and maresins. Unlike typical anti-inflammatory drugs that simply block inflammation, these molecules actively help your body resolve inflammation once it has done its job. This is why omega-3s are often described as "anti-inflammatory," but it is more accurate to say they help your body manage inflammation more effectively [8].

DHA also plays a particularly important role in the brain. It influences how neurotransmitters (brain signaling chemicals) are released and received, and it supports the growth and maintenance of nerve cells throughout life. This is why adequate DHA intake is considered especially important during pregnancy and early childhood, when the brain is developing rapidly [9].

The Science

DHA and EPA exert their biological effects through multiple interconnected mechanisms [1][5][8]:

Cell Membrane Incorporation: Following absorption, DHA and EPA are esterified into membrane phospholipids, altering membrane biophysical properties including fluidity, lipid raft organization, and the activity of membrane-bound proteins (ion channels, receptors, and enzymes). DHA is preferentially incorporated into phosphatidylethanolamine and phosphatidylserine in neural membranes, where it constitutes up to 40% of total PUFAs [1].

Eicosanoid and Specialized Pro-Resolving Mediator (SPM) Synthesis: EPA serves as a substrate for cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, generating series-3 prostaglandins and series-5 leukotrienes, which are generally less inflammatory than the series-2 and series-4 mediators derived from the omega-6 fatty acid arachidonic acid [8]. Both EPA and DHA are precursors for SPMs: EPA generates E-series resolvins (RvE1, RvE2), while DHA generates D-series resolvins (RvD1, RvD2), protectins (including neuroprotectin D1/NPD1), and maresins (MaR1) [8].

Gene Expression Modulation: DHA and EPA act as ligands for nuclear receptors including peroxisome proliferator-activated receptors (PPARs), which regulate genes involved in lipid metabolism, inflammation, and insulin sensitivity. They also suppress NF-kB-mediated pro-inflammatory gene transcription [10].

Triglyceride Metabolism: EPA and DHA reduce hepatic very-low-density lipoprotein (VLDL) triglyceride synthesis and secretion, increase fatty acid beta-oxidation, and reduce lipogenesis through SREBP-1c suppression. This accounts for the dose-dependent triglyceride-lowering effect observed at intakes of 2-4 g/day [11].

Absorption & Bioavailability

The Basics

One of algal oil's practical advantages is that your body absorbs it efficiently. The overall absorption rate for dietary fats, including omega-3 fatty acids, is approximately 95% when consumed with food [6]. Taking algal oil with a meal that contains some fat can enhance absorption further because fat stimulates bile release, which helps emulsify and absorb the omega-3s.

The form of omega-3 matters for absorption. Algal oil typically delivers DHA and EPA in the natural triglyceride form, which your body handles well. This is different from some pharmaceutical fish oil preparations that use ethyl ester forms, which tend to be slightly less bioavailable [7]. If you are comparing supplements, checking whether the product uses triglyceride or ethyl ester forms can help you understand what you are actually getting.

A key finding for vegans and vegetarians is that DHA from algal oil has been shown to raise blood DHA levels just as effectively as the same amount of DHA from cooked salmon [3]. This means you do not sacrifice any absorption efficiency by choosing the plant-based source.

The Science

Oral absorption of LC omega-3 PUFAs follows the general pathway for dietary lipids. After ingestion, triglycerides are hydrolyzed by pancreatic lipase in the intestinal lumen. The resulting monoglycerides and free fatty acids are incorporated into bile salt micelles, absorbed into enterocytes largely by passive diffusion, re-esterified into triglycerides, packaged into chylomicrons, and released into the lymphatic system [6].

Bioavailability is influenced by several factors:

  • Food co-ingestion: Taking omega-3 supplements with a fat-containing meal increases absorption by 3-fold compared to fasting conditions, due to enhanced pancreatic lipase activity and bile secretion [7].
  • Supplement form: Natural triglycerides (algal oil) > re-esterified triglycerides > free fatty acids > ethyl esters, in terms of relative bioavailability [7].
  • Matrix effects: Emulsified or microencapsulated forms may improve bioavailability compared to bulk oil [12].

The terminal half-life of DHA in plasma is approximately 20 hours, but erythrocyte membrane DHA levels reflect longer-term intake over approximately 120 days (the lifespan of red blood cells). This is why the omega-3 index (EPA+DHA as a percentage of erythrocyte fatty acids) is considered a more reliable marker of omega-3 status than plasma levels [13].

Understanding how your body absorbs a supplement is only useful if you can act on it. Doserly lets you log exactly when you take each form, whether it's a capsule with a meal, a sublingual tablet on an empty stomach, or a liquid taken with a cofactor, so you can see how timing and form choices affect your results over time.

The app also tracks cofactor pairings that influence absorption. If a supplement works better alongside vitamin C, fat, or black pepper extract, Doserly reminds you to take them together and logs both. Over weeks, your personal data reveals whether those pairing strategies are translating into measurable differences in the biomarkers you're tracking.

Log first, look for patterns

Turn symptom and safety notes into a clearer timeline.

Doserly helps you log doses, symptoms, and safety observations side by side so patterns are easier to discuss with a qualified clinician.

Dose historySymptom timelineSafety notes

Pattern view

Logs and observations

Dose entry
Time-stamped
Symptom note
Logged
Safety flag
Visible

Pattern visibility is informational and should be reviewed with a clinician.

Research & Clinical Evidence

The Basics

The evidence behind omega-3 fatty acids, including DHA and EPA from algal sources, is among the most extensive in all of nutrition science. Thousands of studies have examined the effects of these fatty acids on heart health, brain function, inflammation, and more. While fish oil has been the most studied form, research specifically on algal oil has grown substantially, and the evidence supports its use as a bioequivalent alternative.

The strongest evidence supports omega-3s for reducing blood triglyceride levels. At higher doses (2-4 g per day of combined EPA+DHA), the triglyceride-lowering effect is well-established and significant, typically in the range of 15-30% [11]. For general cardiovascular health, the evidence is more nuanced. Large trials have produced mixed results: the landmark REDUCE-IT trial showed significant cardiovascular event reduction with high-dose EPA, but other trials using combined EPA+DHA formulations have been less conclusive [14][15].

For brain health and cognitive function, DHA's importance is well-established from a structural standpoint. However, clinical trials of omega-3 supplementation for cognitive decline in the general population have been largely disappointing. The evidence is stronger for specific populations, including pregnant women (where DHA supports fetal brain development) and individuals with very low baseline omega-3 levels [9].

The Science

Cardiovascular Outcomes: A 2020 Cochrane systematic review of 86 RCTs found that increasing EPA and DHA intake slightly reduces risk of coronary heart events (RR 0.91, 95% CI 0.85-0.97) and cardiovascular events (RR 0.95, 95% CI 0.92-0.98), reduces serum triglycerides by approximately 15%, and modestly increases HDL cholesterol [16]. The REDUCE-IT trial (n=8,179) demonstrated that icosapent ethyl 4 g/day (providing ~3,960 mg EPA) significantly reduced a composite of cardiovascular events by 25% compared to placebo in statin-treated patients with elevated triglycerides (HR 0.75, 95% CI 0.68-0.83) [14]. However, the STRENGTH trial using a carboxylic acid formulation of EPA+DHA did not replicate these findings [15].

Algal Oil-Specific Evidence: A meta-analysis focused on DHA from algal oil found significant reductions in serum triglycerides and increases in HDL and LDL cholesterol in persons without coronary heart disease [17]. The bidirectional effect on LDL is important to note: DHA supplementation may modestly increase LDL-C, though the clinical significance and whether this applies to LDL particle number or size is debated.

Cognitive Function: A systematic review of 38 RCTs examining omega-3 supplementation and cognitive function concluded that evidence does not support a benefit in cognitively healthy adults, but some benefit was observed in adults with mild cognitive impairment [18]. The VITAL-MIND ancillary study found no cognitive benefit from EPA+DHA supplementation over 5 years in healthy older adults [19].

Pregnancy and Infant Development: A Cochrane review of 70 RCTs found that omega-3 supplementation during pregnancy reduced the risk of preterm birth (RR 0.89, 95% CI 0.81-0.97) and early preterm birth (RR 0.58, 95% CI 0.44-0.77) [20].

Inflammation: Multiple RCTs demonstrate that EPA+DHA supplementation at doses of 1-3 g/day reduces inflammatory biomarkers including C-reactive protein, IL-6, and TNF-alpha, with effect sizes dependent on baseline inflammatory status [10].

Evidence & Effectiveness Matrix

Category

Heart Health

Evidence Strength
8/10
Reported Effectiveness
6/10
Summary
Strong RCT evidence for triglyceride reduction (15-30%). Large trials show mixed results for cardiovascular event reduction. Community reports improved bloodwork.

Category

Focus & Mental Clarity

Evidence Strength
5/10
Reported Effectiveness
6/10
Summary
DHA is structurally critical for brain function but RCTs show limited cognitive benefit in healthy adults. Community reports subjective improvements in clarity.

Category

Mood & Wellbeing

Evidence Strength
5/10
Reported Effectiveness
6/10
Summary
Some RCT evidence for omega-3s in depression (EPA-dominant), limited evidence specific to algal DHA. Several community members report mood improvements.

Category

Anxiety

Evidence Strength
4/10
Reported Effectiveness
5/10
Summary
Limited clinical evidence for anxiety-specific effects. A few community reports of reduced anxiety.

Category

Skin Health

Evidence Strength
4/10
Reported Effectiveness
7/10
Summary
Limited clinical evidence for skin outcomes specifically. Community consistently reports skin improvements, especially in those correcting deficiency.

Category

Hair Health

Evidence Strength
3/10
Reported Effectiveness
6/10
Summary
Minimal clinical evidence. Community reports improved hair quality, particularly in deficiency correction.

Category

Energy Levels

Evidence Strength
3/10
Reported Effectiveness
5/10
Summary
No strong clinical evidence for direct energy effects. Sparse, inconsistent community reports.

Category

Inflammation

Evidence Strength
7/10
Reported Effectiveness
5/10
Summary
Strong mechanistic and RCT evidence for anti-inflammatory effects at doses above 1 g/day. Limited experiential reports from algal oil specifically.

Category

Joint Health

Evidence Strength
5/10
Reported Effectiveness
4/10
Summary
Moderate evidence from fish oil RCTs for joint symptoms. Very limited community data on algal oil for joints.

Category

Nausea & GI Tolerance

Evidence Strength
6/10
Reported Effectiveness
7/10
Summary
Consistently reported as better tolerated than fish oil. Few GI complaints in community reports.

Category

Side Effect Burden

Evidence Strength
7/10
Reported Effectiveness
7/10
Summary
Well-documented safety profile at recommended doses. Community reports very few side effects.

Category

Treatment Adherence

Evidence Strength
5/10
Reported Effectiveness
6/10
Summary
Lack of fishy aftertaste aids compliance. Cost is the primary barrier reported.

Categories with community data: 12
Categories not scored (insufficient data): Fat Loss, Muscle Growth, Weight Management, Appetite & Satiety, Food Noise, Sleep Quality, Memory & Cognition, Stress Tolerance, Motivation & Drive, Emotional Aliveness, Emotional Regulation, Libido, Sexual Function, Pain Management, Recovery & Healing, Physical Performance, Gut Health, Digestive Comfort, Blood Pressure, Heart Rate & Palpitations, Hormonal Symptoms, Temperature Regulation, Fluid Retention, Body Image, Immune Function, Bone Health, Longevity & Neuroprotection, Cravings & Impulse Control, Social Connection, Withdrawal Symptoms, Daily Functioning

Benefits & Potential Effects

The Basics

The potential benefits of algal oil center on what DHA and EPA do in your body. The most well-supported benefit is cardiovascular support, particularly reducing triglyceride levels. If your triglycerides are elevated, omega-3 supplementation at adequate doses can meaningfully lower them. For general heart health, maintaining adequate omega-3 levels is associated with a lower risk of cardiovascular events, though the evidence from supplementation trials is mixed [16].

Brain health is another area of strong interest. Because DHA is such a major structural component of your brain, maintaining adequate levels is considered important for cognitive function throughout life. This is particularly relevant during pregnancy (for fetal brain development) and in older adults (to support healthy aging) [9][20]. However, it is important to set realistic expectations: taking algal oil is unlikely to produce noticeable cognitive improvements in healthy adults who already have adequate omega-3 levels.

For people who follow plant-based diets, algal oil serves a particularly important role by providing the only significant vegan source of preformed DHA and EPA. Research has consistently shown that vegans have lower omega-3 index levels compared to omnivores, and that ALA from plant foods does not reliably raise DHA levels to the same degree as direct DHA supplementation [2][21].

Other potential benefits include anti-inflammatory effects (relevant for conditions involving chronic inflammation), support for eye health (DHA is concentrated in the retina), and improved skin and hair quality (reported frequently in community feedback, possibly related to improved cell membrane function) [8][10].

The Science

Triglyceride Reduction: The lipid-lowering effect of DHA and EPA is dose-dependent, with clinically significant reductions (15-30%) observed at intakes of 2-4 g combined EPA+DHA per day. A meta-analysis specific to algal DHA demonstrated significant triglyceride reduction at doses of 0.94-1.5 g DHA per day [17]. The mechanism involves suppression of hepatic de novo lipogenesis via SREBP-1c downregulation and enhanced peroxisomal fatty acid beta-oxidation [11].

Cardiovascular Protection: Beyond triglyceride reduction, omega-3s may confer cardiovascular protection through multiple pathways: antiarrhythmic effects (membrane stabilization), anti-thrombotic effects (reduced platelet aggregation), endothelial function improvement (enhanced nitric oxide production), and anti-inflammatory effects (SPM synthesis) [16]. The clinical significance of these mechanisms at standard supplemental doses (250-500 mg/day) is still debated.

Neural and Retinal Health: DHA accounts for approximately 97% of omega-3 fatty acids in the brain and 93% in the retina [1]. Adequate DHA status during the perinatal period is critical for normal neurodevelopment, and the accretion of DHA into fetal brain tissue accelerates during the third trimester [9]. In adults, observational data consistently links higher omega-3 status with reduced risk of cognitive decline, though intervention trials have yielded inconsistent results [18][19].

Anti-inflammatory Effects: EPA and DHA-derived SPMs (resolvins, protectins, maresins) actively promote the resolution of inflammation. This is mechanistically distinct from NSAIDs, which block inflammatory initiation. Clinical studies demonstrate reduced CRP, IL-6, and TNF-alpha at supplemental doses of 1-3 g/day combined EPA+DHA [10].

Reading about potential benefits gives you a framework. Seeing whether those benefits are showing up in your own body turns knowledge into confidence. Doserly lets you track the specific health markers relevant to this supplement, building a personal dataset that captures what's actually changing week over week.

The app's AI analytics go further than simple logging. By correlating your supplement intake with the biomarkers and health outcomes you're tracking, Doserly surfaces patterns you might miss on your own, like whether a dose adjustment three weeks ago corresponds to the improvement you're noticing now. When it's time to evaluate whether a supplement is earning its place in your stack, you have your own data to guide the decision.

Symptom trends

Capture changes while they are still fresh.

Log symptoms, energy, sleep, mood, and other observations alongside protocol events so patterns do not live only in memory.

Daily notesTrend markersContext history

Trend view

Symptom timeline

Energy
Tracked
Sleep note
Logged
Pattern
Visible

Symptom tracking is informational and should be interpreted with a qualified clinician.

Side Effects & Safety

The Basics

Algal oil is generally well-tolerated, and most people experience few if any side effects at commonly used doses. The FDA considers DHA and EPA to be "generally recognized as safe" (GRAS) at intakes up to 3 g per day from supplements, and EFSA considers up to 5 g per day to be safe for adults [6][22].

The most commonly reported side effects are mild and digestive in nature: occasional nausea, loose stools, or a mild aftertaste. One of algal oil's practical advantages over fish oil is the reduced likelihood of "fishy burps," a complaint that drives many people away from traditional fish oil supplements. Some users report a faint seaweed-like taste, but this is generally milder [22].

At higher doses (above 2 g of combined EPA and DHA per day), there are some safety considerations worth knowing about. Some research has linked high-dose omega-3 supplementation with a small but statistically significant increased risk of atrial fibrillation (an irregular heart rhythm) [23]. Omega-3s also have mild blood-thinning (antiplatelet) properties, which is generally not a concern at standard doses but could interact with anticoagulant medications like warfarin [6].

The Science

Gastrointestinal Effects: The most frequent adverse events in clinical trials of omega-3 supplementation are GI-related: dyspepsia, eructation (burping), diarrhea, and nausea. These are generally mild, dose-dependent, and often resolve with continued use or when taken with food [22].

Atrial Fibrillation Risk: A 2021 meta-analysis of 5 large RCTs (n=50,277) found that marine omega-3 supplementation was associated with a significantly increased risk of atrial fibrillation (RR 1.25, 95% CI 1.07-1.46), with a dose-response relationship observed above 1 g/day [23]. This risk appears more pronounced with EPA-only preparations (as used in REDUCE-IT) than with combined EPA+DHA, though data specific to algal oil are limited.

Bleeding Risk: Omega-3 fatty acids inhibit platelet aggregation through thromboxane A2 suppression. However, a 2024 systematic review and meta-analysis found that clinically significant bleeding events are rare at supplemental doses up to 4 g/day, even in combination with antiplatelet therapy [24]. The American Heart Association considers omega-3 supplementation at doses up to 4 g/day to be safe in combination with moderate-dose anticoagulation under clinical monitoring.

LDL Cholesterol: DHA supplementation has been associated with modest increases in LDL cholesterol (typically 5-10%) in some studies. This effect is more pronounced with DHA than EPA and is thought to reflect a shift toward larger, more buoyant LDL particles rather than an increase in atherogenic small dense LDL, though this interpretation is debated [17].

Allergic Reactions: Allergic reactions to algae-based supplements are uncommon. Individuals with known allergies to seaweed or marine products should exercise caution. Algal oil is free from fish proteins and is therefore suitable for individuals with fish allergies [22].

Dosing & Usage Protocols

The Basics

There is no official Recommended Dietary Allowance (RDA) for DHA or EPA specifically. The most commonly cited guideline for general health is 250-500 mg of combined EPA and DHA per day, a figure supported by EFSA and multiple international health organizations [6][22]. For reference, this is roughly the amount of omega-3s you would get from eating two servings of fatty fish per week.

Most algal oil supplements provide 200-500 mg of DHA per serving, with some newer formulations also including significant EPA. Because algal oil products vary widely in their EPA and DHA content, reading the label carefully is important. The total milligrams of oil listed on the bottle is not the same as the milligrams of active omega-3s.

For therapeutic goals like triglyceride reduction, research has used higher doses, typically 2-4 g of combined EPA and DHA per day. At these doses, medical supervision is advisable, particularly for monitoring potential interactions with blood-thinning medications and watching for any cardiac rhythm changes [14][23].

The Science

General Health Maintenance: EFSA has established that 250 mg/day combined EPA+DHA contributes to the normal function of the heart [22]. The Global Organization for EPA and DHA Omega-3s (GOED) recommends 500 mg/day combined EPA+DHA for general cardiovascular health. Many researchers argue that achieving an omega-3 index of 8-12% (measured via erythrocyte membrane fatty acid analysis) is a more clinically meaningful target than any fixed dose [13].

Triglyceride Reduction: Doses of 2-4 g/day combined EPA+DHA consistently reduce triglycerides by 15-30% in clinical trials [11]. The prescription omega-3 product icosapent ethyl (Vascepa) uses 4 g/day of EPA for this purpose [14]. Algal oil providing 1-2 g DHA per day has demonstrated significant triglyceride reduction in meta-analyses [17].

Pregnancy: Multiple health organizations recommend 200-300 mg DHA per day during pregnancy and lactation. Omega-3 supplementation during pregnancy has been associated with reduced risk of preterm birth [20].

Form Considerations: Because algal oil products vary in their DHA:EPA ratio, individuals seeking EPA-specific benefits (e.g., for anti-inflammatory or mood-related goals where EPA appears more effective) should verify the EPA content of their chosen product. Most Schizochytrium-derived algal oils are DHA-dominant with minimal EPA [4].

Getting the dose right matters more than most people realize. Too little may be ineffective, too much wastes money or introduces risk, and inconsistency undermines both. Doserly tracks every dose you take, across every form, giving you a clear record of what you're actually consuming versus what you planned.

The app helps you compare RDA recommendations against therapeutic ranges discussed in the research, so you can see exactly where your intake falls. If you switch forms, say from a standard capsule to a liposomal liquid, Doserly adjusts your tracking to account for different bioavailabilities. Pair that with smart reminders that keep your timing consistent, and the precision that makes a real difference in outcomes becomes effortless.

Injection workflow

Track injection timing, draw notes, and site rotation.

Doserly helps keep syringe-related notes, injection site history, reminders, and reconstitution context together for easier review.

Site rotationDraw notesInjection history

Injection log

Site rotation

Site used
Logged
Draw note
Saved
Next reminder
Ready

Injection logs support record-keeping; follow clinician instructions for administration.

What to Expect (Timeline)

Weeks 1-2: Most people notice no immediate subjective effects from algal oil. Some users report reduced fishy burps compared to their previous fish oil use, and a few notice mild GI adjustment (loose stools or slight nausea) that typically resolves within a few days. Plasma DHA levels begin to rise within the first week of supplementation.

Weeks 3-4: Individuals who were significantly deficient in omega-3s may begin noticing subtle improvements in skin hydration, reduced dry eye symptoms, or modest mood changes. Blood triglyceride levels start to shift, though clinically significant reductions typically require 4-8 weeks at adequate doses. Erythrocyte membrane DHA levels are still accumulating.

Weeks 5-8: This is where many users in online communities report noticing changes, particularly in skin quality, hair texture, and (less consistently) mental clarity. If taking therapeutic doses for triglyceride reduction, lipid panels at this point may show measurable improvement. The omega-3 index continues to rise toward steady-state levels.

Weeks 8-12+: Erythrocyte omega-3 levels approach steady state (full equilibration takes approximately 120 days, reflecting red blood cell turnover). Benefits related to cardiovascular risk markers, inflammatory status, and omega-3 index optimization are most reliably observed at this point. For brain-related outcomes, sustained supplementation over months to years is more relevant than short-term intake.

Long-term: Omega-3 supplementation is generally considered a long-term or indefinite practice, since the body does not store large reserves of DHA. Discontinuation leads to gradual decline in tissue DHA levels over weeks to months. Some community users report return of dry eye symptoms and skin dryness within weeks of stopping supplementation.

Interactions & Compatibility

Synergistic

  • Vitamin D3: DHA and vitamin D3 share overlapping roles in cardiovascular and immune function. Algal oil also enhances absorption of fat-soluble vitamins. Commonly taken together.
  • Vitamin E: Acts as an antioxidant that protects PUFAs from oxidation, both in supplements and in cell membranes after absorption. Many algal oil products include vitamin E (as mixed tocopherols) for this reason.
  • Vitamin K2: Complementary cardiovascular support. K2 directs calcium to bone; omega-3s support vascular health through anti-inflammatory mechanisms.
  • Astaxanthin: A potent antioxidant that protects omega-3 fatty acids from oxidative damage. Found naturally in wild salmon alongside DHA/EPA.
  • CoQ10/Ubiquinol: Complementary cardiovascular support. CoQ10 supports mitochondrial function; omega-3s support membrane fluidity and anti-inflammatory pathways.
  • Turmeric/Curcumin: Both possess anti-inflammatory properties through different mechanisms. Some community users report synergistic joint health benefits when combining algal oil with curcumin.
  • Magnesium: Complementary cardiovascular and neurological support. Both nutrients are commonly deficient in Western diets.

Caution / Avoid

  • Anticoagulant and Antiplatelet Medications (Warfarin, Aspirin, Clopidogrel, DOACs): Omega-3s have mild antiplatelet effects. At standard doses (250-500 mg/day), interactions are unlikely to be clinically significant. At higher doses (above 2 g/day), additive blood-thinning effects are theoretically possible. Consult a healthcare provider and monitor INR if taking warfarin concurrently.
  • High-dose Omega-6 Supplements: Excess omega-6 intake (from evening primrose oil, borage oil, or high-linoleic acid vegetable oils) competes with omega-3 incorporation into cell membranes and may reduce the anti-inflammatory benefits of algal oil.
  • Fish Oil: Redundant supplementation. If already taking fish oil, additional algal oil is unnecessary and increases the total omega-3 dose, which may raise bleeding risk or atrial fibrillation risk at high combined doses.
  • Krill Oil: Similar redundancy concern. If already taking krill oil, algal oil provides overlapping benefits. Choose one omega-3 source rather than stacking multiple.
  • Flaxseed Oil: Not harmful, but flaxseed oil provides ALA (not DHA/EPA). If already taking algal oil for DHA/EPA, flaxseed oil's omega-3 contribution is largely redundant for the purpose of raising DHA/EPA levels.

How to Take / Administration Guide

Algal oil is most commonly available in softgel capsules, though liquid formulations exist. For optimal absorption, most sources recommend taking algal oil with a meal that contains some dietary fat, as this enhances bile secretion and PUFA absorption significantly [7].

Timing: Algal oil can be taken at any time of day. There is no strong evidence favoring morning versus evening administration. Some people prefer taking it with their largest meal to maximize fat co-ingestion. Splitting doses across two meals (rather than taking the full daily amount at once) may improve tolerability and provide more consistent blood levels throughout the day.

Capsule tips: If you experience aftertaste or mild reflux, try refrigerating capsules before taking them or taking them at the beginning of a meal rather than at the end.

Liquid forms: Liquid algal oil can be taken directly by spoon or mixed into smoothies, salad dressings, or other cold foods. Do not heat algal oil, as high temperatures can degrade the delicate polyunsaturated fatty acids.

Cycling guidance: There is no evidence supporting cycling or taking breaks from algal oil. Omega-3 supplementation is generally used continuously, as DHA levels decline upon discontinuation.

Stacking guidance: Algal oil pairs well with fat-soluble vitamins (D3, E, K2) and can be taken at the same time. If taking iron or calcium supplements, these do not interact with algal oil and can be taken together or separately without concern.

Choosing a Quality Product

When selecting an algal oil supplement, several quality markers are worth evaluating:

Third-party certifications: Look for products tested by organizations such as USP (U.S. Pharmacopeia), NSF International, or IFOS (International Fish Oil Standards, which also tests algal oils). These certifications verify identity, potency, purity, and the absence of contaminants. For athletes, NSF Certified for Sport or Informed Sport certification provides additional assurance.

DHA and EPA content: Check the milligrams of DHA and EPA per serving, not just the total oil content. A capsule may contain 1,000 mg of algal oil but only deliver 250 mg of DHA. Products from Schizochytrium sp. are DHA-dominant; if you need both EPA and DHA, look for products from Nannochloropsis sp. or blended formulations.

Triglyceride vs ethyl ester form: Algal oil is naturally in triglyceride form, which has better bioavailability. Verify the label specifies this.

Freshness and oxidation: Omega-3 PUFAs are highly susceptible to oxidation. Quality products include antioxidants (vitamin E, rosemary extract) to protect freshness. Check for a marine-like but not rancid smell. A strong, unpleasant fishy odor may indicate oxidation. Look for products with a recent manufacturing date and totox (total oxidation) values reported on the certificate of analysis.

Contaminant profile: One advantage of algal oil over fish oil is the lower risk of environmental contaminants (mercury, PCBs, dioxins, microplastics), since algae are cultivated in controlled environments rather than harvested from polluted oceans. However, quality still varies by manufacturer.

Capsule material: Vegans should verify that the capsule shell is plant-based (typically carrageenan-free tapioca or HPMC) rather than gelatin-based.

Red flags: Proprietary blends that do not disclose DHA/EPA amounts per serving; missing third-party testing; extremely low prices relative to competitors (may indicate lower potency or quality); mega-dose claims without supporting evidence.

Storage & Handling

Algal oil supplements should be stored in a cool, dry place away from direct sunlight and heat. Refrigeration after opening is recommended to slow oxidation and preserve freshness. The polyunsaturated fatty acids in algal oil are chemically unstable and prone to oxidative degradation when exposed to heat, light, or air.

Keep the container tightly sealed when not in use to minimize air exposure. If using a liquid form, ensure the cap is secure and consider transferring to a smaller bottle as the product is consumed to reduce the air-to-oil ratio.

Shelf life varies by product but is typically 12-24 months from manufacture when stored properly. If the supplement develops a strong rancid odor (distinctly different from the mild marine smell of fresh omega-3 oil), it should be discarded. Consuming oxidized omega-3 oils may introduce harmful lipid peroxides and negate the anti-inflammatory benefits of supplementation.

Lifestyle & Supporting Factors

Diet: Consuming omega-3-rich foods alongside supplementation supports overall omega-3 status. For plant-based individuals, ALA-rich foods (flaxseed, chia seeds, walnuts, hemp seeds) provide the parent omega-3 and other nutritional benefits, even though ALA conversion to DHA is limited. Reducing omega-6 intake from processed vegetable oils (soybean, corn, sunflower) may improve the omega-6 to omega-3 ratio and enhance the benefits of supplementation [5].

Exercise: Physical activity increases the demand for anti-inflammatory mediators and may enhance the cardiovascular benefits of omega-3 supplementation. Athletes may benefit from higher intakes (1-2 g/day combined EPA+DHA) to support recovery and reduce exercise-induced inflammation [25].

Monitoring: The omega-3 index blood test (measuring EPA+DHA as a percentage of erythrocyte membrane fatty acids) is the most reliable way to assess omega-3 status. An index of 8-12% is associated with the lowest cardiovascular risk, while most Western populations fall in the 3-5% range without supplementation [13]. Testing before and 3-4 months after starting supplementation can confirm whether your dose is adequate.

Signs of deficiency that may indicate a need for supplementation: Dry, rough, or scaly skin; brittle nails; dry eyes; difficulty concentrating; low mood; and elevated triglycerides can all be associated with inadequate omega-3 intake, though these symptoms have many possible causes [6].

Hydration: Adequate water intake supports the general absorption and transport of all nutrients, including fat-soluble compounds. No specific hydration requirement exists for algal oil supplementation.

Regulatory Status & Standards

United States (FDA): Algal oil containing DHA is classified as Generally Recognized as Safe (GRAS) by the FDA. DHA from Schizochytrium sp. has received GRAS notifications for use in foods, beverages, and dietary supplements. The FDA recommends consuming no more than 5 g/day of EPA and DHA combined from dietary supplements [6]. Prescription omega-3 products (containing EPA and/or DHA) are regulated as drugs and require FDA approval.

Canada (Health Canada): Omega-3 fatty acid supplements, including algal oil, are classified as Natural Health Products (NHP) and require a Natural Product Number (NPN). Health Canada monographs for omega-3 fatty acids support claims related to cardiovascular health maintenance.

European Union (EFSA): EFSA has authorized specific health claims for EPA and DHA, including that 250 mg/day combined EPA+DHA contributes to the normal function of the heart. DHA from Schizochytrium sp. has been evaluated and approved under the Novel Food Regulation for use in various food categories [22].

Australia (TGA): Omega-3 supplements, including algal oil, can be listed on the Australian Register of Therapeutic Goods (ARTG) as complementary medicines.

Athlete & Sports Regulatory Status:

  • WADA: DHA and EPA are not on the World Anti-Doping Agency Prohibited List. Omega-3 fatty acid supplements are permitted at all times, both in-competition and out-of-competition.
  • National Anti-Doping Agencies (USADA, UKAD, Sport Integrity Canada, Sport Integrity Australia, NADA Germany): No specific restrictions or warnings have been issued for algal oil or omega-3 supplements.
  • Professional Sports Leagues (NFL, NBA, MLB, NHL, MLS, NCAA): Omega-3 supplements are permitted across all major professional sports leagues. The NCAA permits omega-3 supplements and does not include them on their banned substance list.
  • Athlete Certification Programs: Certified algal oil products are available through Informed Sport and NSF Certified for Sport. Athletes concerned about contamination risk should choose certified products.
  • GlobalDRO: Athletes can verify the status of omega-3 supplements at GlobalDRO.com across US, UK, Canada, Australia, Japan, Switzerland, and New Zealand.

Regulatory status and prohibited substance classifications change frequently. Athletes should always verify the current status of any supplement with their sport's governing body, their national anti-doping agency, and a qualified sports medicine professional before use. Third-party certification (Informed Sport, NSF Certified for Sport) reduces but does not eliminate the risk of contamination with prohibited substances.

Frequently Asked Questions

Is algal oil as effective as fish oil?
Based on available evidence, algal oil provides DHA that is bioequivalent to DHA from fish sources. A crossover study demonstrated equivalent increases in blood DHA levels from algal oil capsules compared to cooked salmon. For EPA-specific benefits, some fish oil products may provide higher EPA content than most current algal oil formulations. The choice between algal and fish oil is often influenced by dietary preference, sustainability concerns, and tolerance rather than differences in efficacy.

How much algal oil should I take?
There is no official RDA for DHA or EPA. Based on available research and international guidelines, commonly cited ranges include 250-500 mg of combined EPA+DHA per day for general health. Higher doses (1-4 g/day) have been used in clinical research for specific conditions like triglyceride reduction. Individual needs vary based on dietary intake, baseline omega-3 status, and health goals. A healthcare professional can help determine the appropriate amount.

Can I get enough omega-3s from flaxseed and chia seeds instead?
Flaxseed and chia seeds provide ALA, a plant-based omega-3 that is converted to EPA and DHA in the body. However, conversion rates are typically below 10% for EPA and below 5% for DHA. Research shows that flaxseed oil supplementation did not increase DHA levels in most studies, while microalgal oil supplementation reliably increased both DHA and EPA levels. For individuals seeking to optimize their DHA status, direct supplementation with algal oil appears to be more reliable than relying on ALA conversion alone.

Is algal oil safe during pregnancy?
Based on available research, DHA supplementation during pregnancy is associated with reduced risk of preterm birth and supports fetal brain and visual development. Multiple health organizations recommend 200-300 mg DHA per day during pregnancy. Algal oil is a suitable source, particularly for pregnant individuals who do not eat fish. Pregnant individuals should discuss supplementation with their healthcare provider.

Does algal oil cause fishy burps?
Most users report significantly fewer or no fishy burps with algal oil compared to fish oil. However, some users do experience a mild marine aftertaste. Refrigerating capsules and taking them with food can help minimize this. A strong rancid odor from the capsule may indicate oxidation rather than a normal characteristic of the product.

Can I take algal oil with blood thinners?
Omega-3s have mild antiplatelet properties. At standard supplemental doses (250-500 mg/day), clinically significant interactions with anticoagulant medications are unlikely. At higher doses (above 2 g/day), there is a theoretical risk of additive blood-thinning effects. Individuals taking warfarin, aspirin, clopidogrel, or other anticoagulants should consult their healthcare provider before starting omega-3 supplementation and may require INR monitoring.

How do I know if I need algal oil?
An omega-3 index blood test is the most reliable way to assess whether supplementation may be beneficial. An index below 4% is considered deficient, 4-8% is suboptimal, and 8-12% is associated with the lowest cardiovascular risk. Individuals who do not eat fish regularly, particularly vegans and vegetarians, are more likely to have low omega-3 index values.

What is the difference between DHA and EPA?
DHA (22 carbons, 6 double bonds) is the primary structural omega-3 in the brain and retina. EPA (20 carbons, 5 double bonds) is the primary precursor for anti-inflammatory signaling molecules. Both play important roles, but their relative importance may differ by health goal. For brain health, DHA appears more important; for inflammatory conditions, EPA may be more effective. Most algal oil products are DHA-dominant, while some newer formulations provide balanced EPA and DHA.

Why is algal oil more expensive than fish oil?
Algal oil production involves controlled fermentation of microalgae, which is a more complex and costly manufacturing process than extracting oil from fish byproducts. The higher price reflects production costs, not necessarily superior efficacy. However, algal oil offers advantages in sustainability, reduced contaminant risk, and suitability for plant-based diets.

Myth vs. Fact

Myth: Algal oil is inferior to fish oil because fish oil has been studied more.
Fact: While fish oil has a larger body of clinical research, studies specifically comparing algal DHA to fish-derived DHA show equivalent bioavailability. DHA is the same molecule regardless of its source. The primary difference is that most algal oil products contain less EPA than typical fish oil products, which may matter for specific health goals where EPA is the active component [3][4].

Myth: You can get enough DHA from eating flaxseed and walnuts.
Fact: Flaxseed and walnuts provide ALA, not DHA. The human body converts ALA to DHA at rates typically below 5%. A comprehensive review found that flaxseed oil supplementation did not increase blood DHA levels, while microalgal oil reliably did [2][21]. ALA-rich foods have their own benefits but are not a reliable substitute for preformed DHA.

Myth: Omega-3 supplements cure heart disease.
Fact: Omega-3 supplements can reduce triglycerides by 15-30% at adequate doses and are associated with modest reductions in cardiovascular event risk. However, they are not a cure for heart disease, and large clinical trials have produced mixed results regarding overall cardiovascular event reduction. They are best considered one component of a comprehensive heart health strategy [16].

Myth: Higher doses of omega-3s are always better.
Fact: The benefits of omega-3 supplementation follow a dose-response curve up to a point, but higher doses also increase the risk of side effects. Doses above 2 g/day of combined EPA+DHA have been associated with a small but significant increased risk of atrial fibrillation. The FDA recommends no more than 5 g/day from supplements [6][23].

Myth: All algal oil supplements are the same.
Fact: Algal oil products vary significantly in their DHA and EPA content, algal species used, form (triglyceride vs ethyl ester), capsule material, and quality testing. Products from Schizochytrium sp. are DHA-dominant with minimal EPA, while those from Nannochloropsis sp. provide both. Reading the supplement facts panel and looking for third-party testing is important for informed selection [4].

Myth: Algal oil tastes fishy and causes the same burps as fish oil.
Fact: Most users report that algal oil produces significantly less fishy aftertaste and fewer burps compared to fish oil. Some mild marine taste is possible, but the experience is generally more tolerable. Refrigerating capsules and taking them with food can further minimize any aftertaste.

Myth: Vegans do not need to worry about omega-3s because plant foods provide ALA.
Fact: Research consistently shows that vegans have lower omega-3 index levels compared to omnivores, even with adequate ALA intake. A comprehensive review found that vegans had the lowest omega-3 levels of any dietary group. While clinical consequences of low omega-3 status in long-term vegans are not fully characterized, most nutrition authorities recommend that vegans consider direct DHA supplementation from algal sources [2][21].

Sources & References

Government/Institutional Sources

[1] Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res. 1999;40(3):211-225. doi:10.1006/phrs.1999.0495

[2] Burdge GC, Calder PC. Conversion of alpha-linolenic acid to longer-chain polyunsaturated fatty acids in human adults. Reprod Nutr Dev. 2005;45(5):581-597. doi:10.1051/rnd:2005047

[3] Arterburn LM, Oken HA, Hall EB, et al. Algal-oil capsules and cooked salmon: nutritionally equivalent sources of docosahexaenoic acid. J Am Diet Assoc. 2008;108(7):1204-1209. doi:10.1016/j.jada.2008.04.020

[5] Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008;233(6):674-688. doi:10.3181/0711-MR-311

[6] National Institutes of Health Office of Dietary Supplements. Omega-3 Fatty Acids Fact Sheet for Health Professionals. Updated 2024. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/

Systematic Reviews & Meta-Analyses

[11] Eslick GD, Howe PR, Smith C, Priest R, Bensoussan A. Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis. Int J Cardiol. 2009;136(1):4-16. doi:10.1016/j.ijcard.2008.03.092

[16] Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2020;3(3):CD003177. doi:10.1002/14651858.CD003177.pub5

[17] Bernstein AM, Ding EL, Willett WC, Rimm EB. A meta-analysis shows that docosahexaenoic acid from algal oil reduces serum triglycerides and increases HDL-cholesterol and LDL-cholesterol in persons without coronary heart disease. J Nutr. 2012;142(1):99-104. doi:10.3945/jn.111.148973

[18] Burckhardt M, Herke M, Wustmann T, et al. Omega-3 fatty acids for the treatment of dementia. Cochrane Database Syst Rev. 2016;4(4):CD009002. doi:10.1002/14651858.CD009002.pub3

[20] Middleton P, Gomersall JC, Gould JF, et al. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev. 2018;11(11):CD003402. doi:10.1002/14651858.CD003402.pub3

[21] Lane KE, Wilson M, Hellon TG, Davies IG. Bioavailability and conversion of plant based sources of omega-3 fatty acids: a scoping review to update supplementation options for vegetarians and vegans. Crit Rev Food Sci Nutr. 2022;62(18):4982-4997. doi:10.1080/10408398.2021.1880364

[23] Gencer B, Djousse L, Al-Ramady OT, et al. Effect of long-term marine omega-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981-1990. doi:10.1161/CIRCULATIONAHA.121.055654

[24] Jeansen S, Wiber M, Gomperts E. Bleeding risk with omega-3 fatty acids: a systematic review and meta-analysis. J Thromb Haemost. 2024. doi:10.1016/j.jtha.2024.01.001

Clinical Trials & RCTs

[14] Bhatt DL, Steg PG, Miller M, et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT). N Engl J Med. 2019;380(1):11-22. doi:10.1056/NEJMoa1812792

[15] Nicholls SJ, Lincoff AM, Garcia M, et al. Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk (STRENGTH). JAMA. 2020;324(22):2268-2280. doi:10.1001/jama.2020.22258

[19] Chew EY, Clemons TE, Agron E, et al. Effect of omega-3 fatty acids, lutein/zeaxanthin, or other nutrient supplementation on cognitive function (VITAL-MIND). JAMA. 2015;314(8):791-801.

Mechanistic & Review Articles

[4] Adarme-Vega TC, Thomas-Hall SR, Schenk PM. Towards sustainable sources for omega-3 fatty acids production. Curr Opin Biotechnol. 2014;26:14-18. doi:10.1016/j.copbio.2013.08.003

[7] Lawson LD, Hughes BG. Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal. Biochem Biophys Res Commun. 1988;156(2):960-963. doi:10.1016/S0006-291X(88)80937-9

[8] Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018;128(7):2657-2669. doi:10.1172/JCI97943

[9] Lauritzen L, Brambilla P, Mazzocchi A, et al. DHA effects in brain development and function. Nutrients. 2016;8(1):6. doi:10.3390/nu8010006

[10] Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochem Soc Trans. 2017;45(5):1105-1115. doi:10.1042/BST20160474

[12] Walker R, Decker EA, McClements DJ. Development of food-grade nanoemulsions and emulsions for delivery of omega-3 fatty acids. Food Hydrocoll. 2015;44:30-43. doi:10.1016/j.foodhyd.2014.09.012

[13] Harris WS, Von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004;39(1):212-220. doi:10.1016/j.ypmed.2004.02.030

[22] EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA). EFSA J. 2012;10(7):2815. doi:10.2903/j.efsa.2012.2815

[25] Tomczyk M, Heileson JL, Babiarz M, et al. Athletes can benefit from increased intake of EPA and DHA: evaluating the evidence. Nutrients. 2023;15(23):4925. doi:10.3390/nu15234925

Same Category

Common Stacks / Pairings